Bryan Patraw
Nurse Practitioner · Malone, NYNPI 1851939466
Payments from drug & device makers
Across 147 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$396
- Novo Nordisk$361
- AbbVie$333
- GSK$316
- Bayer$272
- Lilly USA, LLC$222
- plus $983 from 18 others
What the payments were for
- Food & beverage$2,883100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $396 |
| Novo Nordisk | 21 | $361 |
| AbbVie | 20 | $333 |
| GSK | 14 | $316 |
| Bayer | 9 | $272 |
| Lilly USA, LLC | 13 | $222 |
| Amgen | 14 | $200 |
| Boehringer Ingelheim | 9 | $190 |
| Merck | 6 | $99 |
| Almatica Pharma LLC | 4 | $96 |
| Sunovion Pharmaceuticals Inc. | 6 | $63 |
| Esperion Therapeutics, Inc. | 3 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Lifescan, Inc. | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Eisai Inc. | 1 | $21 |
| Novartis | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Exact Sciences | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Abbott | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$123
- TRELEGY ELLIPTA$115
- BREZTRI$112
How this compares
$2,883 in reported general payments places this provider in the 90th percentile of 4,112 nurse practitioner providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 31 | $51,321 |
| RybelsusSemaglutide | 24 | $36,368 |
| FarxigaDapagliflozin Propanediol | 23 | $36,094 |
| TrulicityDulaglutide | 25 | $35,761 |
| EliquisApixaban | 24 | $28,732 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $22,546 |
| WegovySemaglutide | 15 | $21,402 |
| JardianceEmpagliflozin | 12 | $21,245 |
| XareltoRivaroxaban | 29 | $20,752 |
| Aimovig AutoinjectorErenumab-Aooe | 16 | $20,153 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $19,516 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 12 | $17,296 |
| JanuviaSitagliptin Phosphate | 11 | $16,156 |
| GemtesaVibegron | 15 | $10,501 |
| MyrbetriqMirabegron | 16 | $10,184 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Wegovy | $361 | $109,09170 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $396 | $65,88560 claims |
| Lilly USA, LLCTrulicity | $222 | $35,76125 claims |
| MerckJanumet Xr, Januvia | $99 | $33,45223 claims |
| Boehringer IngelheimJardiance | $190 | $21,24512 claims |
| GSKTrelegy Ellipta | $316 | $19,51617 claims |
| AbbVieSynthroid | $333 | $1,43127 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,112 nurse practitioner providers in New York.
Other nurse practitioner in Malone
- Patricia McGoldrickNew York$202K
- Michelle DartSyracuse$95K
- Susan KreppelWilliamsville$67K
- Kerry AhernEast Syracuse$55K
- Valerie StanleyAlbany$55K
- Jodi LogerfoNew York$48K
- Grace WlasowiczRochester$41K
- Melissa LevinElmhurst$34K
- Carla JungquistCanandaigua$28K
- Kelly WilmarthJohnson City$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.